Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | SLC16A3 | O15427 | 4/20 | 0.32 |
| ▸ | SLC16A1 | P53985 | 4/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5246666 | 0.80 | POLB (0.34) | KDM4ELMNASLC16A3SLC16A1 | |
| SCHEMBL716222 | 0.79 | KDM4E (0.36) | KDM4ELMNAPKMKMT2ASLC16A3 | |
| SCHEMBL28672471 | 0.79 | LPAR1 (0.31) | KDM4ELMNAPKMKMT2ASLC16A3 | |
| SCHEMBL9805814 | 0.79 | CISD1 (0.33) | KDM4ESLC16A3SLC16A1 | |
| SCHEMBL31613436 | 0.77 | KDM4E (0.34) | KDM4ELMNASLC16A3SLC16A1 | |
| SCHEMBL28670905 | 0.77 | LPAR1 (0.34) | KDM4ESLC16A3SLC16A1 | |
| SCHEMBL28689614 | 0.76 | LPAR1 (0.39) | KDM4ELMNAPKMKMT2ASLC16A3 | |
| SCHEMBL3163653 | 0.76 | CYP2C9 (0.34) | KDM4ECYP2C9SLC16A3SLC16A1 | |
| SCHEMBL3133006 | 0.75 | — | — | |
| SCHEMBL698917 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220023480-A1 | METHODS, COMPOSITIONS AND ARTICLES FOR OLFACTORY-ACTIVE SUBSTANCES | ENVIROSCENT, INC. (US) | 2022-01-27 | — | — | US | claimed |
| EP-2552499-B1 | ARTICLES FOR OLFACTORY-ACTIVE SUBSTANCES | ENVIROSCENT INC (US) | 2021-12-01 | — | — | EP | claimed |
| US-11167055-B2 | Methods, compositions and articles for olfactory-active substances | ENVIROSCENT, INC. (US) | 2021-11-09 | — | — | US | claimed |
| US-10987445-B2 | Methods, compositions and articles for olfactory-active substances | ENVIROSCENT, INC. (US) | 2021-04-27 | — | — | US | claimed |
| US-20180326109-A1 | METHODS, COMPOSITIONS AND ARTICLES FOR OLFACTORY-ACTIVE SUBSTANCES | ENVIROSCENT, INC. (US) | 2018-11-15 | — | — | US | claimed |
| US-20170266333-A1 | METHODS, COMPOSITIONS AND ARTICLES FOR OLFACTORY-ACTIVE SUBSTANCES | ENVIROSCENT, INC. (US) | 2017-09-21 | — | — | US | claimed |
| US-9694096-B2 | Methods compositions and articles for olfactory-active substances | ENVIROSCENT, INC. (US) | 2017-07-04 | — | — | US | claimed |
| US-9132204-B2 | Methods, compositions and articles for olfactory-active substances | ENVIROSCENT, INC. (US) | 2015-09-15 | — | — | US | claimed |
| EP-2552499-A1 | METHODS, COMPOSITIONS AND ARTICLES FOR OLFACTORY-ACTIVE SUBSTANCES | Enviroscent, Inc. (US) | 2013-02-06 | — | — | EP | claimed |
| US-20110262377-A1 | Methods, Compositions and Articles for Olfactory-Active Substances | ENVIROSCENT, INC. (US) | 2011-10-27 | — | — | US | claimed |
| WO-2011123723-A1 | METHODS, COMPOSITIONS AND ARTICLES FOR OLFACTORY-ACTIVE SUBSTANCES | ENVIROSCENT, INC. (US) | 2011-10-06 | — | — | WO | claimed |
| US-20250304529-A1 | BIOBASED CYANOACRYLATE COMPOUND | BOSTIK SA (FR) | 2025-10-02 | — | — | US | disclosed |
| EP-4532465-A1 | BIOBASED CYANOACRYLATE COMPOUND | Bostik SA (FR) | 2025-04-09 | — | — | EP | disclosed |
| WO-2023232948-A1 | BIOBASED CYANOACRYLATE COMPOUND | BOSTIK SA (FR) | 2023-12-07 | — | — | WO | disclosed |
| US-20230389959-A1 | Methods and Devices for Conduit Occlusion | FEMASYS INC. | 2023-12-07 | — | — | US | disclosed |
| US-20090024155-A1 | Methods and Devices for Conduit Occlusion | FEMASYS, INC. | 2009-01-22 | — | — | US | disclosed |
| US-20090024108-A1 | Methods and Devices for Delivery of Compositions to Conduits | FEMASYS, INC. | 2009-01-22 | — | — | US | disclosed |
| EP-1722732-A2 | METHODS AND DEVICES FOR CONDUIT OCCLUSION | FEMASYS INC. (US) | 2006-11-22 | — | — | EP | disclosed |
| WO-2005082299-A2 | METHODS AND DEVICES FOR CONDUIT OCCLUSION | FEMASYS INC. (US) | 2005-09-09 | — | — | WO | disclosed |
| US-20050187561-A1 | Methods and devices for conduit occlusion | FEMASYS, INC. (US) | 2005-08-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250304529-A1 | BIOBASED CYANOACRYLATE COMPOUND | BAP1, CBR1, CBR3 | KDM4E 1134/4885LMNA 992/4885PKM 3029/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.